MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$42,406K
Free Cash flow
$3,197K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Depreciation and amortization
Stock-based compensation
Change in fair value of other as...
Others
Negative Cash Flow Breakdown
Acquisitions, net of cash acquir...
Purchase of held-to-maturity inv...
Taxes paid related to net share ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-10,516
2,154
-8,833
50,180
Change in gain on sale of business
0
-344
-3,439
60,435
Depreciation and amortization
8,515
3,060
3,008
5,177
Stock-based compensation
3,706
5,035
6,586
11,246
Change in fair value of warrant liabilities
-71
-1,459
-1,416
-2,862
Change in fair value of other assets and liabilities
-
-3,444
1,037
-
Excess of lease liability over operating right-of-use assets
-
-
0
0
Transaction costs paid related to sale of business
-
-
1,417
5,964
Gain on lease modification
-
-
0
-
Acquisition consideration allocated to seller transaction expenses
-
-
0
44,339
Impairment of intangible assets
-
-
0
0
Impairment of property and equipment
-
-
1,673
-
Realized loss from sale of short-term investments
-
-
0
-5,195
Realized foreign exchange gain
-
-
0
798
Change in fair value of other assets and liabilities
2,066
-
-
-
Accretion of interest income on held-to-maturity securities
181
265
482
1,732
Deferred tax expense (benefit)
-19
-77
-126
558
Non-cash capital contribution
-333
-
-
-
Other
99
27
83
388
Prepaid expenses and other current assets
577
-383
2,462
-776
Accounts receivable
666
-149
3,483
8,551
Other non-current assets
1
-78
0
-666
Operating right-of-use assets/lease liabilities
-42
-73
-2
90
Accounts payable and accrued expenses
-487
-2,158
-6,017
8,395
Deferred revenue
-12
-3
1,684
-
Other current liabilities
-
-
-
1,583
Increase Decrease In Other Operating Capital Net
-
12
-
-
Net cash provided by / (used in) operating activities
5,687
3,885
-8,307
-40,607
Acquisitions, net of cash acquired
34,823
-
1,361
65,174
Cash transfer related to sale of business
0
290
1,569
1,241
Capitalized software development costs
314
302
157
1,258
Purchase of property and equipment, net of proceeds from disposal
2,490
5,179
1,848
7,747
Purchase of held-to-maturity investments
6,254
0
0
146,258
Proceeds from maturities of held-to-maturity investments
0
30,500
23,200
203,000
Proceeds from sale of short-term investments
-
-
0
70,163
Net cash (used in) / provided by investing activities (includes discontinued operations see note 5)
-43,881
24,729
18,265
51,485
Proceeds from the exercise of common stock options
3
52
54
139
Taxes paid related to net share settlement of equity awards
4,206
582
1,796
7,309
Repurchase and retirement of common stock
-
-
0
0
Payments for debt issuance costs
9
329
-
-
Net cash used in financing activities
-4,212
-859
-1,742
-7,170
Effect of foreign exchange rate changes on cash balances
0
0
0
-339
Net (decrease) / increase in cash and cash equivalents and restricted cash
-42,406
27,755
8,216
3,369
Cash and cash equivalents and restricted cash - beginning
58,987
31,232
23,016
19,647
Cash and cash equivalents and restricted cash - ending
16,581
58,987
31,232
23,016
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Depreciation and
amortization
$8,515K
Stock-based compensation
$3,706K
something is missing
$3,456K
Change in fair value of
other assets and...
$2,066K
Non-cash capital
contribution
-$333K
Other
$99K
Operating right-of-use
assets/lease liabilities
-$42K
Net cash provided by
/ (used in)...
$5,687K
Canceled cashflow
$12,530K
Net (decrease) /
increase in cash and cash...
-$42,406K
Canceled cashflow
$5,687K
Proceeds from the
exercise of common stock...
$3K
Net loss
-$10,516K
Accounts receivable
$666K
Prepaid expenses and
other current assets
$577K
Accounts payable and
accrued expenses
-$487K
Accretion of interest
income on...
$181K
Change in fair value of
warrant liabilities
-$71K
Deferred tax expense
(benefit)
-$19K
Deferred revenue
-$12K
Other non-current
assets
$1K
Net cash (used in) /
provided by investing...
-$43,881K
Net cash used in
financing activities
-$4,212K
Canceled cashflow
$3K
Acquisitions, net of cash
acquired
$34,823K
Purchase of
held-to-maturity investments
$6,254K
Purchase of property and
equipment, net of proceeds...
$2,490K
Capitalized software
development costs
$314K
Taxes paid related to
net share...
$4,206K
Payments for debt
issuance costs
$9K
Buy us a coffee
Strata Critical Medical, Inc. (SRTA)
Strata Critical Medical, Inc. (SRTA)